Choroidal neovascularization (CNV) is a rare complication after laser photocoagulation for disorders such as central serous chorioretinopathy (CSC).
Methods
We report 2 patients who developed CNV after laser treatment for persistent CSC and were treated by 3 1.25-mg intravitreal injections of bevacizumab in 1-month intervals.
Results
In both patients, best-corrected visual acuity improved from 20/120 to 20/80 and from counting fingers at 3 feet to 20/100 over 12 months of follow-up.
Conclusions
The favorable outcome suggests that intravitreal injection of bevacizumab may be beneficial for patients who develop CNV after laser photocoagulation. The favorable outcome may be related to the limited pathology.
GassJ.D.M.. Photocoagulation treatment of idiopathic central serous retinopathy.Trans Am Acad Ophthalmol Otolaryngol1977; 83: 456-63.
2.
MatsunagaH., NangohK., UyamaM., NanbuH., FujisekiY., TakahashiK.. Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy.Nippon Ganka Gakkai Zasshi1995; 99: 460-8.
3.
HaT.W., HamD.I., KangS.W.. Management of choroidal neovascularization following laser photocoagulation for central serous chorioretinopathy.Korean J Ophthalmol2002; 16: 88-92.
4.
ChanW.M., LiK.K., LiuD.T., LaiT.Y., ChongK.K., LamD.S.. Photodynamic therapy with verteporfin in laser-induced choroidal neovascularization.Am J Ophthalmol2003; 136: 565-7.
5.
LandersM.B.III, ShawH.E.Jr, AndersonW.B.Jr, SinyaiA.J.. Argon laser treatment of central serous chorioretinopathy.Ann Ophthalmol1977; 9: 1567-72.
